Patent details

EP3616696 Title: ORALLY ADMINISTRABLE ENZALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION

Basic Information

Publication number:
EP3616696
PCT Application Number:
JP2018017159
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187914866
PCT Publication Number:
WO2018199282
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORALLY ADMINISTRABLE ENZALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION
French Title of Invention:
COMPOSITION PHARMACEUTIQUE CONTENANT DE L'ENZALUTAMIDE POUVANT ÊTRE ADMINISTRÉE PAR VOIE ORALE
German Title of Invention:
ORAL VERABREICHBARE ENZALUTAMIDHALTIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG
SPC Number:

Dates

Filing date:
27/04/2018
Grant date:
05/03/2025
EP Publication Date:
04/03/2020
PCT Publication Date:
01/11/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/03/2025
EP B1 Publication Date:
05/03/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/04/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/02/2025
 
 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

Inventor

1

Name:
TAKAGI, Akira
Address:
Japan (JP)

2

Name:
SAKAI, Toshiro
Address:
Japan (JP)

3

Name:
UMEMOTO, Yoshiaki
Address:
Japan (JP)

4

Name:
YOSHIDA, Takatsune
Address:
Japan (JP)

5

Name:
OBA, Shinsuke
Address:
Japan (JP)

6

Name:
KOJIMA, Ryo
Address:
Japan (JP)

7

Name:
NAMIKI, Sachie
Address:
Japan (JP)

8

Name:
AOKI, Hajime
Address:
Japan (JP)

Priority

Priority Number:
2017090300
Priority Date:
28/04/2017
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 9/20; A61K 47/02; A61K 47/32; A61K 31/4166; A61P 13/08; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202510
Publication date:
05/03/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages